Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Assets (2016 - 2025)

Adma Biologics (ADMA) has disclosed Return on Assets for 14 consecutive years, with 0.26% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets fell 18.0% year-over-year to 0.26%, compared with a TTM value of 0.26% through Dec 2025, down 18.0%, and an annual FY2025 reading of 0.28%, down 20.0% over the prior year.
  • Return on Assets was 0.26% for Q4 2025 at Adma Biologics, down from 0.37% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.45% in Q4 2024 and bottomed at 0.34% in Q1 2021.
  • Average Return on Assets over 5 years is 0.0%, with a median of 0.12% recorded in 2023.
  • Peak annual rise in Return on Assets hit 34bps in 2025, while the deepest fall reached -18bps in 2025.
  • Year by year, Return on Assets stood at 0.28% in 2021, then soared by 35bps to 0.18% in 2022, then surged by 64bps to 0.06% in 2023, then skyrocketed by 795bps to 0.45% in 2024, then tumbled by -41bps to 0.26% in 2025.
  • Business Quant data shows Return on Assets for ADMA at 0.26% in Q4 2025, 0.37% in Q3 2025, and 0.39% in Q2 2025.